QIAstat Dx - Respiratory SARS-CoV-2 Panel

Reasons for Undergoing the QIAstat Dx - Respiratory SARS-CoV-2 Panel

There are several key reasons why an individual may undergo the QIAstat Dx respiratory SARS CoV 2 panel:

• Differentiation of Respiratory Pathogens: The panel identifies and differentiates between various respiratory viruses and bacteria, helping in the accurate diagnosis and treatment of respiratory infections like human metapneumovirus (HMPV).
• Diagnosis of COVID-19: The test is used to detect and confirm the presence of SARS-CoV-2 in individuals showing symptoms of COVID-19, enabling prompt diagnosis and appropriate management.
• Rapid Testing: The QIAstat Dx respiratory SARS CoV 2 panel provides quick results, typically within one hour, which is crucial for timely medical intervention and implementation of necessary public health measures.
• Comprehensive Testing: The panel tests for a wide range of respiratory pathogens in a single assay, reducing the need for multiple tests and speeding up the diagnostic process.

List of Parameters Considered During the QIAstat Dx - Respiratory SARS-CoV-2 Panel

The QIAstat Dx respiratory SARS CoV 2 panel identifies nucleic acids of pathogens causing respiratory illnesses. For HMPV (Human Metapneumovirus), it detects a virus linked to respiratory tract infections. Other targets include SARS-CoV-2, adenovirus, influenza A/B, RSV, coronaviruses, rhinovirus/enterovirus, parainfluenza viruses, and bacterial pathogens like Bordetella pertussis and Mycoplasma pneumoniae.

QIAstat Dx - Respiratory SARS-CoV-2 Panel Preparation

The preparation steps for the QIAstat Dx respiratory SARS CoV 2 panel include:

• Sample Collection: A nasopharyngeal swab (NPS) is collected from the individual suspected of having HMPV, COVID-19 or other respiratory infections.
• Automated Processing: The sample is then loaded into the QIAstat-Dx Analyzer 1.0, which performs all the necessary steps automatically, including homogenisation, cell lysis, nucleic acid purification, and PCR amplification.

QIAstat Dx - Respiratory SARS-CoV-2 Panel Results & Interpretation

The results of the QIAstat Dx respiratory SARS CoV 2 panel indicate the presence or absence of the targeted pathogens. Here's how the results should be interpreted:

• Positive Result: Indicates the presence of the specific pathogen(s) detected by the test. For example, a positive result for SARS-CoV-2 confirms COVID-19 infection.
• Negative Result: Indicates that the pathogen(s) were not detected in the sample. However, a negative result does not rule out infection, especially if the sample was collected too early or too late in the course of the disease.
• Interpretation: The test results should be interpreted in conjunction with clinical symptoms, medical history, and other diagnostic findings. The test report will specify which pathogens were detected, and healthcare providers will use this information to guide treatment and management.

Home Collection for QIAstat Dx - Respiratory SARS-CoV-2 Panel

Metropolis Healthcare offers a convenient home sample collection option for the QIAstat Dx respiratory SARS CoV 2 panel, ensuring comfort and safety for patients. A trained phlebotomist will visit your home to collect the necessary samples, maintaining a high standards of sample handling and testing accuracy. This service ensures that you receive timely and reliable results without compromising on the quality of the diagnostic process.

With Metropolis Healthcare's home collection service, you can access quality diagnostic solutions from the comfort of your home, highlighting company's dedication to provide accessible and convenient healthcare for all.